Skip to main content
. 2023 Oct 25;15(21):5136. doi: 10.3390/cancers15215136
ψM Transmembrane potential
7-AAD 7-Aminoactinomycin D
AF Auranofin
ALL Acute lymphoblastic leukemia
ATP Adenosine triphosphate
BCA Bicinchoninic acid
BRCA2 Breast cancer type 2 susceptibility protein
BZ Bortezomib
CI Combination index
CLL Chronic lymphocytic leukemia
CO2 Carbon dioxide
DEVD DNA-binding peptide; substrate for caspase-3
DHE Dihydroethidium
DNA Deoxyribonucleic acid
DTNB 5,5′-dithio-bis (2-nitrobenzoic acid)
DTT Dithiothreitol
FBS Fetal bovine serum
FDA US Food and Drug Administration
GLOBOCAN Global Cancer Observatory
GSH Glutathione
H2AX Histone variant H2AX
HCl Hydrochloric acid
HEPES 4-(2-hydroxyethyl)-1-piperazine ethane sulfonic acid
HGSOC High-grade serous ovarian cancer
HIV Human immunodeficiency virus
HRP Horseradish peroxidase
IC50 Half-maximal inhibitory concentration
IgG Immunoglobulin G
L-BSO L-buthionine sulfoximine
MTT 3-(4,5-dimethylliazol-2-yl)-2,5-diphenyltetrazolium bromide
NAC N-acetyl-L-cysteine
NADPH Nicotinamide adenine dinucleotide phosphate
NRF2 Nuclear factor erythroid 2-related factor 2
NSLC Non-small cell lung cancer
OD Optical density
PARP Poly-adenosine diphosphate (ADP) ribose polymerase
PBS Phosphate-buffered saline
PE Phycoerythrin
P3Cy5 Phycoerythrin-Cyanine®5
PFA Paraformaldehyde
PMSF Phenylmethylsulfonyl fluoride
PS Phosphatidylserine
ROS Reactive oxygen species
SDS Sodium dodecyl sulfate
TBS-T Tris-buffered saline 0.1% Tween 20
TNB 5′-thio-2-nitrobenzoic acid
TrxR Thioredoxin reductase
z-DEVD-fmk Caspase-3 inhibitor